Antihypertensive Drug Industry Propels their Demand After COVID19 Pandemic

Global Antihypertensive Drug Market by Drug Category (Diuretics, ACE inhibitors, Angiotensin converting enzyme, Alpha blockers, Beta blockers, Renin inhibitors, Calcium channel blockers and others), Distribution Channel (Hospital, e-commerce, Retail pharmacy) and Region (North America, Europe, Asia-pacific, LAMEA): Global Forecasts 2017 to 2027 Research Report by AllTheResearch.

The global antihypertensive drug market was valued at USD 29.7 billion in 2020, and it is expected to reach USD 34.1 billion by 2027, with a CAGR of 2.1%, during the forecast period (2021-2027).
Increase in number of cardiovascular diseases, rising stress level, diabetes patients, change in lifestyle pattern are the factors responsible for the growth of antihypertensive drugs Industry.

Request a Sample Report- https://www.alltheresearch.com/sample-request/445

Hypertension is a long-term diseased condition which requires continue medication and regular follow-ups from the medical practitioner. It is the condition when there is elevated blood pressure in arteries, which concise of high blood pressure. Antihypertensive drugs are used to control the blood pressure to normal. Hypertension give rise to many other life-threatening complications like sever heart attack, dementia, heart failure and apparently shows effects on renal system also. Research proves that decrease in blood pressure by 5mmHg can reduce the stroke risk by about 34%, heart disease by 21% and limits the chances of dementia and mortality of cardiovascular diseases.
The classification of antihypertensive drugs works on different parameters. Drugs are broadly classified on the basis of their route of action like diuretics, calcium channel blockers, ace inhibitors, beta-blockers, combination alpha-beta blockers etc. Out of all classes, ACE inhibitors stood to be best tolerant antihypertensive drug which is the most widely used in patients suffering from hypertension. From class of diuretics, Thiazide drug is considered to be the choice of treatment for the patients which reduces the mortality and morbidity rate.

The factors that drive the growth of antihypertensive drug market are the changing life style of people, consumption of junk food, smoking, alcohol, improper diet, insomnia due to stress are the condition which contribute in increase in number of hypertension patients and leaves to increase in demand for antihypertensive drugs. Once the patient is diagnosed with such condition, there is regular demand for consumption of antihypertensive drugs, and this enhances the demand for medication and act as driving factor for the anti-hypertensive drugs market.

Several governments and companies are collaborating and conducting various campaigns associated with the hypertension drive. One of the is “Know your numbers” is the campaign which was intended to celebrate World hypertension day on 17th May by World Health Organization for the purpose of spreading awareness regarding regular check-up of blood pressure. Another campaign initiated by SERVIER which was conducted in collaboration with International Society of Hypertension, to make public aware about hypertension and its treatment.

The emergence of new drug moiety for the treatment of hypertension is invented with the combination of three most potent drugs namely Telmisartan, Amlodipine and Chlorthalidone. These are collectively called as ‘Triple pill’. Use of combination drug therapy provides high protection to the organ as compared with single drug therapy. This new trend of combination therapy proves to be more effective and widely used across the world. Antihypertensive drug market is still believed to be alive and growing as there are lot of opportunities available for new entrants in the antihypertensive drug market.


Key Findings:
- Based on Drug category, calcium channel blockersegment held a significant share of the global antihypertensive drugs market in 2020 and this is expected to continue during the forecast period 2021 to 2027. This can be attributed to high tolerance to geriatric patients.
- Based on distribution channel, the hospitals segment occupied the largest share of the antihypertensive drugs market. This can be attributed to presence of large patient pool.
- Geographically, North America is accounted for the largest share and is expected to witness the significant growth during the forecast period. However, Asia Pacific is expected to observe the fastest growth of antihypertensive drug market during the forecast period.

Recent News of Antihypertensive Drug Market
• In August 2020, according to new study led by researchers at Columbia University Irving Medical Center, Chlorthalidone causes more serious side effects than hydrochlorothiazide while lowering blood pressure.
• In August 2020, according to several published studies medication use for the treatment of high blood pressure may increase the Covid-19 survival rates, and decreases the severity of coronavirus infection, specially in hypertension patients.

Read More Information- https://www.alltheresearch.com/report/445/global-antihypertensive-drug-market

Contact Name: Rohan S.
Email: contactus@alltheresearch.com
Phone: +1 (407) 768-2028

AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realize, that it's not just sheer data points, but the right analysis that creates a difference. While some clients were unhappy with the inconsistencies and inaccuracies of data, others expressed concerns over the experience in dealing with the research-firm. Also, same-data-for-all-business roles were making research redundant. We identified these gaps and built AllTheResearch to raise the standards of research support.

This release was published on openPR.